Consulting and benefits firms projected health care cost increases of roughly 9 to 11 percent heading into 2027, according to host Jacob Emerson.
“projecting healthcare costs increases of anywhere from nine to 11 % going into next year.”

7 Sep 2026 · 24m · David Merritt, Jacob Emerson · 21 quoted facts
Rising health care costs, expected to climb roughly 9 to 11 percent into 2027, are being pushed higher in part by the arbitration process created under the No Surprises Act. David Merritt of the Blue Cross Blue Shield Association argues that a small group of providers and middlemen are exploiting that process to win awards far above market rates, and that those costs flow straight into premiums for employers, unions and families.
The episode moves from the human cost of unaffordable care to the specific mechanics of the dispute process. Merritt says the problem is fixable because it is a process flaw, not an intractable one, and lays out administrative and congressional reforms. The tension is that providers defend their high win rates, and the host notes one named company disputes Merritt's description of it.”
Merritt says awards typically run four to five hundred percent above rates that plans and doctors negotiate locally, with examples like a CT scan normally near $2,100 awarded at almost $40,000. Someone has to pay the difference, and he says it ends up in premiums.
Merritt cites estimates that 40 percent of disputed claims should never have been heard, yet half of those still produce awards. One plan reported a single provider group filing about 350 disputes a day, 80 percent of them ineligible.
Merritt argues arbiters are paid per decision, so they benefit from more volume, and he says their administrative fees grew by more than $1 billion in a couple of years. He says this incentive helps explain high provider win rates.
Merritt says some providers deliberately remain out of network so there is no negotiated price, then use arbitration for routine services. This skips the market-rate benchmark and produces large awards.
Merritt wants early screening of ineligible claims, fee restructuring, more transparency about arbiters, and restoring the qualified payment amount, meaning locally negotiated market rates, as the starting point for awards. He also points to California's state process as a model.
The No Surprises Act banned surprise medical bills, and IDR (independent dispute resolution) is the arbitration system that settles price disputes between insurers and providers. Merritt says awards often far exceed market rates, and employers and unions pay for them through higher premiums.
Merritt cited a Georgetown study putting the cost at $22 billion in just a couple of years, covering administrative fees and above-market awards. He also said the Business Group on Health estimates nearly a third of premium increases can be attributed to it.
The host noted providers win roughly 86 percent of disputes. Merritt rejects the provider argument that this reflects insurers lowballing, saying the arbiters themselves side with providers and are paid for each decision, which encourages more claims.
Merritt wants ineligible claims screened out early, fees restructured, more transparency over arbiters, action against middlemen, and Congress to restore the qualified payment amount, the privately negotiated local market rate, as the benchmark for awards.
No. Merritt and the host also named catastrophic claims, GLP-1 and oncology drugs, provider consolidation, upcoding and AI-enhanced billing. Merritt said IDR is more limited in reach than the others, which affect Medicare, Medicaid, exchanges and employer coverage alike.
Stated by the speakers. Each quote matches the transcript, which shows what was said, not that it is true.
Consulting and benefits firms projected health care cost increases of roughly 9 to 11 percent heading into 2027, according to host Jacob Emerson.
“projecting healthcare costs increases of anywhere from nine to 11 % going into next year.”
The No Surprises Act passed with bipartisan majorities and eliminated surprise medical bills for patients, according to David Merritt.
“the No Surprises Act, the legislation that was actually passed with bipartisan majorities, solved a real problem for patients. And that was eliminating surprise medical bills.”
A Georgetown study cited by David Merritt put the cost of the No Surprises Act arbitration process at $22 billion in a couple of years, including administrative fees and above-market awards.
“researchers at Georgetown put out a study that said in just a couple of years, the price tag on that process is $22 billion.”
David Merritt said the Business Group on Health estimated that nearly a third of current premium increases can be attributed to the IDR problem.
“the business group on health recently estimated that nearly a third of the premium increases that we're seeing can be attributed to this problem.”
David Merritt said the Georgetown study found IDR claims grew by 77 percent in the most recent year.
“That same study said that claims grew by 77 % last year.”
David Merritt said the association estimates 40 percent of IDR claims should not be heard, yet half of those result in awards and required payments.
“our estimates are that 40 % of them should not be heard in the first place, yet half of those actually result in awards and required payments.”
David Merritt cited an IDR award of nearly $500,000 for a breast reduction procedure.
“there was a nearly a $500 ,000 breast reduction.”
David Merritt said IDR awards are typically 400 to 500 percent higher than negotiated market rates.
“And the awards are typically, you know, four to 500 % higher than the market rates.”
The Georgetown research put excess IDR spending at $22 billion over the initial four years, up from an earlier $5 billion estimate, according to Jacob Emerson.
“the $22 billion in excess spending over the initial four years, that's up from an initial $5 billion estimate from the year prior.”
Jacob Emerson said providers have won roughly 86 percent of IDR disputes and that dispute volume reached 2.6 million cases last year, citing Georgetown research.
“I know providers have been winning roughly 86 % of disputes. The dispute volume hit 2.6 million cases last year”
The IDR system is receiving more than 17,000 new disputes roughly every two days, according to Georgetown research cited by Jacob Emerson.
“the system is seeing more than 17 ,000 new disputes roughly every two days.”
David Merritt said administrative fees collected by IDR arbiters grew by more than $1 billion over a couple of years.
“So more than $1 billion and just in the last couple of years.”
The administration finalized an operations rule in May to lower IDR administrative fees and streamline the process, according to Jacob Emerson.
“there was an operations rule finalized by the administration in May to lower administrative fees, trying to streamline some of this process.”
David Merritt said the May operations rule lowered the barrier to filing a claim, which he expects to increase dispute volume.
“it did lower the barrier to file a claim, which we think will simply increase volume.”
David Merritt said one health plan reported a single provider group filing about 350 disputes a day, 80 percent of them ineligible.
“one plan that said a single provider group filed about 350 disputes a day and 80% of them were ineligible.”
David Merritt said Halo MD did not exist before the No Surprises Act and now accounts for more than half of all IDR claims filed.
“there was one company, Halo MD. It didn't exist before the No Surprises Act. And now it accounts for more than half of all claims that are filed.”
HaloMD told Becker's on the record that it is not private equity backed, disputing David Merritt's characterization.
“Halo MD has disputed to us on the record that they are not private equity backed.”
David Merritt said bipartisan leaders in Congress are looking at restoring the qualified payment amount, the privately negotiated local market rate, as the starting point for IDR awards.
“fundamentally restoring the qualified payment amount and those those privately negotiated market rates in each of in each of the local markets.”
David Merritt cited California as a state that has minimized surprise-billing arbitration problems through state-level guardrails.
“You don't see a lot of these problems in states that have a reasonable state process. California is a good example where they've minimized a lot of this because they have good guardrails in place.”
The No Surprises Act Enforcement Act has been introduced in Congress and is not favored by insurers, according to Jacob Emerson.
“the No Surprises Act Enforcement Act introduced. I know that's not in favor by insurers.”
David Merritt said employers have responded to rising costs by increasing coinsurance and cost sharing for employees and trimming benefits.
“employers have really struggled and have made tradeoffs to increase coinsurance and cost sharing with employees. They've trimmed benefits in many cases.”
Sets out who the Blue Cross Blue Shield Association represents and the scale of its reach, which frames the affordability discussion.
“represents every Blue Cross Blue Shield plant across the country. So collectively, we cover, serve, and support more than 115 million Americans”
Merritt ties 2027 cost projections to everyday trade-offs like skipped medications and appointments.
“when the cost of care goes up, the cost of coverage goes up.”
Explains the Georgetown findings, claim volumes and extreme awards that make IDR a major cost pressure.
“the price tag on that process is $22 billion.”
Describes how out-of-network providers and large awards land on self-funded employers and unions.
“someone has to pay in the end.”
Merritt disputes that high win rates reflect underpayment and points to arbiter pay incentives.
“The arbiters themselves, they get paid when they actually make a decision on a claim.”
Shows how employers respond to rising costs by raising cost sharing and trimming benefits.
“employers have really struggled and have made tradeoffs to increase coinsurance and cost sharing with employees.”
Reviews the May operations rule, proposed reforms and the role of Halo MD, including the host's fairness note.
“fundamentally restoring the qualified payment amount and those those privately negotiated market rates”
Merritt urges prompt action and cites California as a state with effective guardrails.
“This is a snowball that is growing.”
GLP wants Medicare Advantage headwinds, a Medicaid landscape that looks different every quarter. Payer leadership right now means making durable decisions in an environment that keeps moving, and the organizations pulling ahead are the ones that stopped waiting for stability before acting. Becker's fifth annual Fall Payer Issues Roundtable convenes more than 500 executive-level attendees and 70-plus speakers November 2nd and 3rd at the Swiss Hotel Chicago. Two days of senior level dialogue on affordability, benefit design, value-based care, and the strategies shaping how care gets financed and delivered.
Featuring a celebrity keynote from Pro Football Hall of Famer, Emmett Smith. Agenda and registration at beckerspayer.com. Click events in the upper right.
Hello, everyone. This is Jacob Emerson with the Becker's Payer Issues podcast. I'm thrilled today to be joined by David Merritt, who serves as Senior Vice President of External Affairs for the Blue Cross Blue Shield Association. David, appreciate you taking the time to chat with me today.
Great to be with you, Jacob. Thanks for the opportunity.
Absolutely. And before we dive into everything we want to talk about, David, and what you are seeing driving up health care costs going into 2027, what's affecting affordability for those you represent, can you just fill in our audience, for those who might not be familiar, the breadth of the companies that you represent, and a little bit more about what your role entails
at the association. Sure. No, happy to start there. Blue Cross Blue Shield Association represents every Blue Cross Blue Shield plant across the country. So collectively, we cover, serve, and support more than 115 million Americans every single day. So that's every single ZEP code. And we've been doing that for nearly 100 years. So we are really part of the fabric of these local communities. We partner with more than 90 % of the doctors and hospitals across the country, and really just trying to balance access to care with affordable coverage so people can get the care they need to keep healthy if they're healthy and get better if they're sick.
So that's really our foremost priority. And my role specifically at the Blues for External Affairs is working with members of the media like yourself, working with policymakers as well, to really make sure that we are trying to prioritize those solutions that actually can bring costs down, that can expand coverage, that can expand access, so people can get care and get the care they deserve.
Yeah. So fair to say you're a busy guy, David. And I appreciate you chatting with us briefly about what you're watching going into next year and what is affecting affordability for who you just mentioned, employers for one in three Americans served by the blues plans. And I know you've seen a lot of the most recent projections from consulting groups, from benefits firms over this last month or so throughout the summer, projecting healthcare costs increases of anywhere from nine to 11 % going into next year.
The drivers, some of the drivers, they're familiar on our end. Catastrophic claims are increasing, especially drug spending around GLP-1s, oncology drugs, provider consolidation. New this year, AI-enhanced billing practices showing up in actuarial reports for the first time. And I know the association has put out some really interesting research around that this year. And then, of course, the IDR process under the No Surprises Act. So all that being said, what are you watching most closely going into next year?
Yeah, well, where we start is just looking at the impact that rising costs have on real families, because this is an abstract for millions of people every day. We're all paying more for gas, for groceries, housing, health care. For folks who are living paycheck to paycheck, it is a daily struggle. And so that's truly what drives us to take on some of these cost drivers. And when you actually add in the family budget and all those things I mentioned, you've got to start making tradeoffs when costs continue to go up across the board.
And in health care, we see folks skipping or stretching a medication because it costs too much. We see folks skipping an appointment because of the cost. And that's why for Blue Cross Blue Shield, fixing the affordability crisis truly is our number one priority. It has been. We have been, I think, the most vocal payer out there trying to push solutions on many of those cost drivers that you just mentioned, because we do hear from our customers every single day, the businesses that we partner with.
You know, you hear folks say that this is unsustainable and certainly 10 plus percent increases year over year is unsustainable. And that's why we are pushing so hard on solutions that can truly try and mitigate some of these pressures. The hard thing, though, is that it's no single cost driver. Like you just mentioned three or four of them. You know, it's a combination of all these factors. But the bottom line is when the cost of care goes up, the cost of coverage goes up.
And that's truly just simple math. You know, it's like it's like when you build a house or build a car. If the cost of the materials go up, the cost of the house or the car goes up. And so we are truly trying to drive solutions that can bring down the pressure on those cost drivers and hopefully bring some relief to to the American people.
Yeah, no, absolutely. And I appreciate you humanizing what some of the real life impact of these more granular issues that you and I are talking about on a daily basis and how it affects real people. It seemed like this year, especially on insurers' earnings calls, in rate filings for marketplace coverage, we were seeing the IDR process, the arbitration system under the No Surprises Act, really start to pop up more and more. And I know it's not a new issue in terms of a cost pressure, but it seems to be or it is intensifying.
So I wonder if you can contextualize that for us. Like we mentioned, there's a lot of different things pressuring costs going into next year. What's what's the where does the no surprises, the IDR process fit into that broader picture? Just how big of a deal is this right now?
Yeah, that's a great question and a really timely one, because it is undoubtedly one of those pressures that is driving premiums higher. And what's unfortunate about it is that the No Surprises Act, the legislation that was actually passed with bipartisan majorities, solved a real problem for patients. And that was eliminating surprise medical bills. Millions of people got these from doctors and hospitals and others that were unexpected and often ran thousands of dollars. The problem, though, is that the arbitration process, now how to resolve those billing disputes between payers and providers, the process is now driving overall costs higher, not just for patients, but businesses every day.
Just last week, researchers at Georgetown put out a study that said in just a couple of years, the price tag on that process is $22 billion. dollars. That's in administrative fees. That's in awards that are above market rates. And the business group on health recently estimated that nearly a third of the premium increases that we're seeing can be attributed to this problem. And unfortunately, when you look at the trends, they really are getting worse. And it's being, honestly, it's just being gamed by a small group of private equity-backed providers, and they're maximizing revenue.
Because when you look at the data, there are two things that are really driving it, and that's the volume of claims and the amount of the awards. So on the claims and the volume, it truly is being like flooded with these cases, many of which aren't even ineligible, or they are ineligible. That same study said that claims grew by 77 % last year. We're talking millions and millions of claims over the estimated, you know, 10 ,000, 20 ,000 claims that CMS originally estimated.
And of those, our estimates are that 40 % of them should not be heard in the first place, yet half of those actually result in awards and required payments. And that's the second part of the problem is that the awards we're seeing are just egregious. You know, there was a nearly a $500 ,000 breast reduction. There was a CT scan that normally costs around $2 ,100 was almost $40 ,000. So it's a group of providers that are staying out of network so they can go through that process to get those awards.
And the awards are typically, you know, four to 500 % higher than the market rates. And And the market rates are negotiated by plans and doctors every day in their local markets. And so those higher payments really do ripple through the system, you know, flowing down into premiums. And that's why we have really tried to put targeted reforms, tightening eligibility, you know, arbiter oversight, and really just some guardrails over the account over the entire process to really just rein it in because it is a broken process that really is driving costs higher.
Yeah, no, absolutely. And I know just going off of that Georgetown study that you just cited, put out last week, the $22 billion in excess spending over the initial four years, that's up from an initial $5 billion estimate from the year prior. I know providers have been winning roughly 86 % of disputes. The dispute volume hit 2.6 million cases last year, and it's running even higher in the first half of this year. And then, of course, the system is seeing more than 17 ,000 new disputes roughly every two days.
And that's according to the Georgetown research. We've seen a lot of, like you mentioned, plastic surgery, radiology, orthopedic cases seem to really be at the heart of a lot of this. And I know this has also become a really hot button political issue because every time new research is put out, a new news article, new analysis, another side comes in with their perspective on why that new research is quote unquote wrong. And so for the health plan executives listening in, David, can you walk us through how is this actually flowing down to premiums, what the real world cost impact looks like for the employers, ultimately for the members?
I know you said a third of premium increases now can trace back to this. But can you explain the pipeline from the IDR, the arbitration system back down to the premium itself?
Sure. When a provider stays out of network, that means there is not a negotiated market price between local providers and local plants. To us, that is the most important data point is because that is a market rate. Like that is what the private parties have agreed upon. And when that is not utilized or at least not even part of the equation, you have groups that will stay out of network and deliberately use this as a business model.
So they will continue to seek care, but use this process for routine services. You just mentioned a few of them. And what we're seeing is that when they get awards that are 400, 500, 1 ,000 % higher than those market rates, someone has to pay in the end. And the way that businesses have seen this, self-funded companies across the country, and we're talking huge companies, You know, Fortune 10 companies, Fortune 100 companies, who in the end, when they provide coverage to their members, and they are the ones that are truly paying tens of millions of dollars that are unexpectedly, I mean, they're basically getting surprise build at this point.
And they have to come up with hundreds of millions of dollars in these awards. They have to make up for that somewhere. And in the end, where it's made up is in higher premiums. It's just one of those underlying cost pressures that businesses, unions as well, unions that run their own health plans that cover tens of millions of union members across the country, they are also seeing the same pressures. So when you have bipartisan policymakers seeing the consequences of this broken process, you also see businesses and unions coming together.
I mean, very seldomly do you see businesses and labor working together. But we have been locked in arms because we are partners with trying to drive costs down. And reforms to the process can actually drive those costs down. But we really need to put those guardrails in. So those initial claims don't result in higher premiums when those hundreds of millions of dollars in awards fall on to businesses and unions and consumers across the country.
Certainly. And I'm glad you brought that last point up there, David, around how public employers are really being affected by this, because we've heard similar from other insurers out there talking about how unions, municipalities, state employee plans have really been hit hard disproportionately by this issue. I wonder, you know, one critique we've heard about the high provider win rate from provider groups saying that that just reflects money that they were originally owed, that that reflects insurers lowballing them from the beginning, in their words.
How would you respond to that critique?
Yeah, I don't buy it, because when these awards are so outrageous and so unreasonable, when they are, you know, 500% above a truly a market rate that has been privately negotiated between the parties, that doesn't mean that we're lowballing. That means that the arbiter themselves, the IDR entity, is choosing to side with the providers. And the reasons we see that, honestly, are because the process is truly designed to incentivize more volume. The arbiters themselves, they get paid when they actually make a decision on a claim.
So and we've seen tremendous growth in the administrative fees that these arbiters are actually taking in over the years. So more than $1 billion and just in the last couple of years. And so when you have providers who want to stay out of network and maximize maximize their revenue through this process and you have arbiters who want them to submit claims so they can rule on the claim and make the award and therefore themselves get paid.
it really is incentivizing more volume and higher awards. And so we just need to bring balance to the process. And we have some solutions that we've been pushing along with those businesses, along with those unions and patient groups that shine a spotlight into the arbiters themselves to ensure that they're being balanced and not biased, rooting out those ineligible claims to begin with, and then using real market rates to help determine more reasonable awards. We think that it's a, you know, a lot of things in health care seem intractable.
The good news is this is a process problem. And I know it's complicated, but at the same time, there are reforms that can go into place to really turn around some of the egregious trends that we're seeing.
Yeah, no, certainly. And I do want to get into possible solutions and reforms in just a second. But I did want to make sure to ask you in terms of what you're hearing and seeing from employers, how this is all affecting their benefit design decisions, especially as we go into next year renewal season, and how the leaders, the health plan leaders listening to this right now should be thinking about protecting their employer clients around this issue.
Yeah. Well, employer-provided coverage has been a bedrock. It's been the foundation of our healthcare system and certainly our coverage for many, many decades. And so what we should be focusing on are solutions that actually bring down costs and reduce the burden that businesses across the country, both big and small, are facing every day. And like I started with those individuals, businesses make those same kind of tradeoffs when they see upcoding and consolidation and the pressures that you mentioned, not to mention just the typical pressure we see on pharmaceutical pricing.
So employers have really struggled and have made tradeoffs to increase coinsurance and cost sharing with employees. They've trimmed benefits in many cases. And that puts a burden on their employees to access the care that they need. And so that's only sustainable for a short amount of time. That's why these long-term root causes of rising costs are so important to address, because the longer that businesses shoulder that burden of rapidly rising health care costs, the worse the consequences and the worse the tradeoffs are going to be when it comes to covering their employees.
And I'd also even say all these cost drivers that we've talked about, except for IDR, which is somewhat limited, it affects every single market, whether you're covered through Medicare or Medicaid, the exchanges or private insurance through an employer. You know, rising hospital costs, consolidation, technology, GLP-1 expansion, all of those are cost pressures no matter where you get your coverage. So that's why we at the Blues place such a high priority, because it really does affect everyone across the country.
So, David, in talking about what could be done about all of this, obviously, as you know, there was an operations rule finalized by the administration in May to lower administrative fees, trying to streamline some of this process. But insurers, broadly, the industry, including the association, said it didn't go far enough to address some of these issues. And then legislatively, we've seen the No Surprises Act Enforcement Act introduced. I know that's not in favor by insurers. And of course, the physician groups, the AMA and other specialty physician groups are fighting to preserve this process as it is.
And so what's the path forward look like in Congress? And what are you hearing in terms of what actually might be possible right now?
You mentioned the operations rule, and there was some cleanup that was necessary, and overall it was helpful, though it did lower the barrier to file a claim, which we think will simply increase volume. We think you need to decrease volume and really target it to those disputes that are more legitimate. So while it was helpful, I think it did have a pretty significant consequence. I think the first I've mentioned is just stopping these ineligible cases. And you can do that by restructuring the fees and also by just screening them out early in the process so that, you know, arbiters are not incentivized to move them through and be compensated, even though they may be ineligible.
And also it will make the process just more efficient. You know, we had one plan that said a single provider group filed about 350 disputes a day and 80% of them were ineligible. And just by gumming up the works, it allows the more high cost claims to, you know, sometimes go unanswered because we simply can't respond to all of them. So I think on the front end, that's the most important thing that happened. Secondly, real transparency and accountability for these decisions.
We've been, you know, happy to see a lot more coverage and by Beckers and many other national outlets that are looking at this and shining a spotlight on the problem. And we think that that leads to accountability for the decisions and for the process. It has been a black box and we think there are reforms that can happen to provide that transparency and accountability. And then I think looking at the middlemen who are really abusing this process by making it a business model.
You know, there was one company, Halo MD. It didn't exist before the No Surprises Act. And now it accounts for more than half of all claims that are filed. So they are, you know, a private equity-backed company. And they're doing what they should, you know, trying to maximize revenue. But it's maximizing revenue on the backs of businesses and unions and patients. And we think that there are some reforms that really need to happen to clean up the process.
The ones I just walked through are more on the administrative side. And we think the Trump administration has acknowledged that there are lots of problems with this process, that they can take action to move. But Congress is increasingly being asked to take a second look at it as well. And there are bipartisan leaders in both the House and Senate that are looking at this and fundamentally restoring the qualified payment amount and those those privately negotiated market rates in each of in each of the local markets.
That is where we should start the debate around what is a reasonable award and centering that as part of the congressional debate, we think can really turn around the problem.
Yeah, absolutely. And just for fairness sake, David, I do want to make sure to put it on the record for our listeners that Halo MD has disputed to us on the record that they are not private equity backed. But before we go, anything else we're missing on this topic? Anything else you want to make sure to highlight or any advice you'd want to offer the other industry leaders listening in?
Yeah. Look, this is a process that can be fixed. This is not one of those intractable problems. We just need policymakers to really take action. And, you know, the trend lines are really troubling. And every business we talk to, every union group we talk to, if these continue to drive and escalate at this rate that we're seeing, it will cost tens and hundreds of billions of dollars over the course of the coming years. So this is a snowball that is growing.
It's still fairly small, but it can pick up a lot of speed if these trends aren't reversed. And we know that there are common sense solutions that both regulators and legislators can take to clean up the process. And there's something states can even do. This is all about the federal process. You don't see a lot of these problems in states that have a reasonable state process. California is a good example where they've minimized a lot of this because they have good guardrails in place.
So we just want policymakers to take a really close look and take immediate action before the problem gets too big.
David, can't thank you enough for taking the time to chat with us, for simplifying what is a very complicated issue. Thank you for being with us.
Glad to do it. Appreciate you having me on, Jacob. Thanks.
Absolutely. Anytime. And to our listeners, if you'd like to listen to more podcasts from Becker's, you can visit Becker's Hospital Review dot com. Thank you.